NHS England Newcomers to Help Drive Five-Year Plan
NHS England has elected three new appointments to strengthen its work on primary care, drive improved cancer services, and to lead the commissioning of specialised hospital services. A move that chief executive Simon Steven says will help “turbo-charge” implementation of the Five Year Forward View.
Practising GP Arvind Madan is now NHS England’s Director of Primary Care, providing clinical leadership for the transformation of primary care provision. He will retain a regular clinical commitment looking after patients in East London, and will also serve as a deputy national medical director to Sir Bruce Keogh. Dr Madan brings a strong track record of using new technology and redesigned ways of working to improve boost outcomes and value for money.
Cally Palmer has elected as NHS National Cancer Director. She is to lead implementation of the NHS Cancer Taskforce’s five-year strategy for cancer care improvement, as well as new cancer Vanguards using outcomes-based commissioning to redesign care and the patient experience. Ms Palmer is Chief Executive of The Royal Marsden Hospital NHS Foundation Trust, and will retain this role while seconded to NHS England.
Jonathan Fielden is appointed NHS England’s new Director of Specialised Commissioning, to lead work within this area and the development of the national strategy for specialised services. He will also serve as a deputy national medical director to Sir Bruce Keogh. Dr Fielden is currently Medical Director of University College London Hospitals NHS Foundation Trust, a consultant in intensive care medicine and member of a CCG governing body.
Produced by NHS England, Public Heath England, Monitor, the NHS Trust Development Authority, Care Quality Commission and Health Education England, with advice from patient groups, clinicians and independent experts, the Five Year Forward View lays out key areas in which action must be taken to plug the growing health and care divide, fill the gaping hole in finances, and address 21st century challenges.